Envoy Medical says all 56 patients activate Acclaim cochlear implant in pivotal trial
PUBT · 04/22 12:09
Share
Listen to the news
- Envoy Medical reported all 56 patients in its pivotal US trial of fully implanted Acclaim cochlear implant have completed initial activation visits.
- Trial results have not been presented yet; Envoy expects to analyze data once 12-month follow-up is complete for all patients.
- Company plans to submit findings to FDA as part of a Premarket Approval application.
- Update firms up trial timeline, supporting visibility into regulatory milestones for investigational device targeting severe to profound hearing loss.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Envoy Medical Inc. published the original content used to generate this news brief on April 22, 2026, and is solely responsible for the information contained therein.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.
Copyright © 2026 Webull. All Rights Reserved